# CDK inhibitors in cancer therapy, an overview of recent development.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cdk-inhibitors-in-cancer-therapy-an-overview-of-recent-development/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Mengna Zhang,Lingxian Zhang,Ruoxuan Hei,Xiao Li,Haonan Cai,Xuan Wu,Qiping Zheng,Cheguo Cai |
| Citations | 284 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/8167670 |
| OpenAlex ID | https://openalex.org/W3171269824 |
| PMID | 34094661 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Xiao Li](https://scholariq.org/researchers/xiao-li/)
- [Lingxian Zhang](https://scholariq.org/researchers/lingxian-zhang/)

## Paper journal

- [PubMed](https://scholariq.org/journals/pubmed/)

## Paper primary topic

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Paper topics

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer-related Molecular Pathways](https://scholariq.org/topics/cancer-related-molecular-pathways/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.